Collectively, these findings demonstrated that BCKDK‐mediated phosphorylation confers protection against ubiquitin‐proteasome‐mediated degradation of AKT, thereby enhancing its stability, and promotes RCC tumorigenesis via the activation of the AKT/mTOR signaling pathway. The gene discussed is BCKDK; the disease is renal cell carcinoma.